Opinion
Video
Identifying Candidates for RSV Vaccination
Author(s):
A panelist discusses how physicians can partner with pharmacists to identify respiratory syncytial virus (RSV) vaccine candidates among high-risk populations, emphasizing the pharmacist’s role in prevention efforts and the importance of supportive care and awareness of newly approved vaccines and monoclonal antibodies.
Summary for Physicians: At-Risk Populations & Pharmacist’s Role; Treatment Recommendations
High-risk groups for RSV include infants (especially those who are premature or have chronic lung/heart disease), adults 60 years and older, and immunocompromised individuals. Pharmacists can identify vaccine candidates through medication reviews and patient history, focusing on age and chronic conditions.
Current RSV treatment is mainly supportive—hydration, oxygen, and respiratory support as needed. Pharmacists should also be aware of newly approved vaccines and monoclonal antibodies for prevention in high-risk groups.
